NCT06426641

Brief Summary

The purpose of this study was to investigate whether polyethylene (Vitamin E-containing polyethylene), which has been newly introduced and widely used clinically as a biomaterial for tibial inserts in total knee arthroplasty, but whose mid- to long-term clinical results are still unknown, is more effective than conventional polyethylene. Our goal is to clarify through an international multi-center joint study using in vivo polyethylene wear particle analysis, which the investigators developed as a method to provide early feedback, as to whether polyethylene wear debris production in vivo can be reduced.

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
32mo left

Started Dec 2023

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Dec 2023Dec 2028

Study Start

First participant enrolled

December 5, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 23, 2024

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

January 17, 2025

Status Verified

January 1, 2025

Enrollment Period

4.1 years

First QC Date

May 16, 2024

Last Update Submit

January 16, 2025

Conditions

Keywords

Polyethylene wear particle

Outcome Measures

Primary Outcomes (4)

  • Number of polyethylene wear particles

    counts / g (tissue sample)

    Time of revision surgery

  • Equivalent circle diameter of polyethylene wear particles

    Equivalent circle diameter (㎛)

    Time of revision surgery

  • Aspect ratio of polyethylene wear particles

    Aspect ratio

    Time of revision surgery

  • Roundness of polyethylene wear particles

    Roundness

    Time of revision surgery

Secondary Outcomes (9)

  • Body mass index

    Time of revision surgery

  • Knee joint extension angle

    Time of revision surgery

  • Knee joint flexion angle

    Time of revision surgery

  • 2011 Knee Society Score: An "Objective" Knee Score

    Time of revision surgery

  • 2011 Knee Society Score: A Patient Satisfaction Score

    Time of revision surgery

  • +4 more secondary outcomes

Study Arms (3)

polyethylene containing Vitamin E

polyethylene containing Vitamin E

Device: Polyethylene

conventional polyethylene (no highly cross-linking)

conventional polyethylene (no highly cross-linking)

Device: Polyethylene

conventional polyethylene (with highly cross-linking)

conventional polyethylene (with highly cross-linking)

Device: Polyethylene

Interventions

There is no intervention

conventional polyethylene (no highly cross-linking)conventional polyethylene (with highly cross-linking)polyethylene containing Vitamin E

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing revision surgery

You may qualify if:

  • Patients undergoing revision knee arthroplasty within the study period
  • Patients over 20 years old
  • Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
  • Patients who have passed 2 years or more since their first total knee arthroplasty

You may not qualify if:

  • \. Patients who are judged to be unsuitable as research subjects by the research physician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Osaka Metroplitan Univerity

Osaka, 545-8585, Japan

Location

Related Publications (2)

  • Minoda Y, Kobayashi A, Iwaki H, Iwakiri K, Inori F, Sugama R, Ikebuchi M, Kadoya Y, Takaoka K. In vivo analysis of polyethylene wear particles after total knee arthroplasty: the influence of improved materials and designs. J Bone Joint Surg Am. 2009 Nov;91 Suppl 6:67-73. doi: 10.2106/JBJS.I.00447. No abstract available.

  • Minoda Y, Kobayashi A, Iwaki H, Miyaguchi M, Kadoya Y, Ohashi H, Yamano Y, Takaoka K. Polyethylene wear particles in synovial fluid after total knee arthroplasty. Clin Orthop Relat Res. 2003 May;(410):165-72. doi: 10.1097/01.blo.0000063122.39522.c2.

Biospecimen

Retention: SAMPLES WITHOUT DNA

pericapsular tissue, which is removed during surgery

Study Officials

  • Yukihide Minoda, MD, PhD

    Osaka Metropolitan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

May 16, 2024

First Posted

May 23, 2024

Study Start

December 5, 2023

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

January 17, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations